Market Place
Sourcing Support
InnoCare & KeyMed Announce Agreement for Bispecific Antibody
21 Jan 2025 //
BUSINESSWIRE
Mountainfield, China`s Keymed launch biotech with $180M series A
10 Jan 2025 //
FIERCE BIOTECH
Keymed Bio Gets Approval for Stapokibart in Chronic Rhinosinusitis
23 Dec 2024 //
PR NEWSWIRE
Stapokibart Approved In China For Moderate-To-Severe Atopic Dermatitis
12 Sep 2024 //
PR NEWSWIRE
Keymed Biosciences Announces Interim Results for First Half of 2024
27 Aug 2024 //
PR NEWSWIRE
Keymed`s Stapokibart Shows Long-Term Efficacy, Safety In Atopic Dermatitis
02 Jun 2024 //
PR NEWSWIRE
InnoCare and Keymed Jointly Announce Subject Dosed in Trial of CCR8 Monoclonal Antibody ICP-B05
23 Feb 2023 //
BUSINESSWIRE
Keymed, Lepu Enter Global License Agreement with AstraZeneca for CMG901
23 Feb 2023 //
CONTRACT PHARMA
Keymed and Lepu Jointly Announce Agreement with AZ for CMG901
22 Feb 2023 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.